Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination.
Relapsed, refractory lymphoma remains to be a challenge and lacks efficient treatment. Some tumor cells escape from treatment, become resistant to chemotherapeutic agents, and rapidly regenerate into large tumors. Lymphoma cells induce accumulation of Gr-1(+-)CD11b(+) myeloid derived suppressor cell...
Main Authors: | Xue-Jun Zhu, Zhong-Fa Yang, Jin-Yong Zhou, Li Liu, Xue-Mei Sun, Zhen-Fang Fan, Shou-You Hu, Yu-Chao Chen, Wei-Xia Li, Meng Cao, Li-Xin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4504496?pdf=render |
Similar Items
-
Metronomic Chemotherapy Combined with Dendritic Cell Vaccine
Inhibits VEGF Secretion
by: Yan ZHOU, et al.
Published: (2013-09-01) -
Risk Factors of Thromboembolism in Lymphoma Patients Undergoing Chemotherapy and its Clinical Significance
by: Xiao Li MM, et al.
Published: (2021-09-01) -
Different effects of gemcitabine + paclitaxel and gemcitabine + oxaliplatin chemotherapy on the malignant biology of advanced bladder cancer
by: Jun Zhao, et al.
Published: (2017-11-01) -
Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study
by: Liu T, et al.
Published: (2018-10-01) -
Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy
by: PeiJian Peng, et al.
Published: (2016-05-01)